Effect of Betaine and Food on Gastric pH
NCT02758015 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2020-01-23
Summary
Food will decrease stomach acidity due to its buffering effect.This has implications when providing drugs that are dosed with food but require higher levels of stomach acid, such as some medications commonly used for HIV patients. This study will attempt to determine the dose of betaine hydrochloride (over the counter acid supplement) at which the effect of food on stomach acid could be countered. Additionally, this study will evaluate the ability of a natural supplement (betaine hydrochloride) to affect the gastric pH following a standardized meal in healthy volunteers. The investigators predict that 4500mg of betaine hydrochloride will have the greatest effect on gastric pH.
Conditions
- Healthy
Interventions
- OTHER
-
Standardized Meal
- DIETARY_SUPPLEMENT
-
Betaine Hydrochloride 1500mg
Betaine hydrochloride (natural supplement) administered after standardized meal.
- DIETARY_SUPPLEMENT
-
Betaine Hydrochloride 3000mg
Betaine hydrochloride (natural supplement) administered after standardized meal.
- DIETARY_SUPPLEMENT
-
Betaine Hydrochloride 4500mg
Betaine hydrochloride (natural supplement) administered after standardized meal.
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
Leslie Z Benet, PhD · University of California, San Francisco
-
Lynda A Frassetto, MD · University of California, San Francisco
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2018-03-26
- Completion
- 2018-03-26
Countries
- United States
Study Locations
More Related Trials
-
PEA in Functional Dyspepsia
NCT05877781 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
NCT07016269 ·Status: RECRUITING ·Phase: PHASE4
-
Intestinal Adsorbent and Breath Gas Levels
NCT04492839 ·Status: COMPLETED ·Phase: NA
-
Sensitivity and Specificity of the Modified Helicobacter Test INFAI
NCT04294823 ·Status: WITHDRAWN
-
Effect of Secretin in Functional Dyspepsia and Healthy Subjects
NCT03617861 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MCE Direct Visualization of Drug Behavior in Upper-gastrointestinal Tract
NCT04327869 ·Status: COMPLETED
-
Mast Cells in Acid-induced Intestinal Permeability
NCT02664051 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
NCT05655819 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia
NCT03004118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A New Method for Determining Gastric Acid Output Using a Wireless Capsule
NCT00702533 ·Status: COMPLETED
-
Behavioral Therapy in Patients With Rumination
NCT05232097 ·Status: COMPLETED ·Phase: NA
-
Effect of Simethicone on Helicobacter Pylori Detection in Routine Endoscopy
NCT07293234 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Simethicone and N-acetylcysteine in Upper Endoscopy - Prospective Double-blinded Randomized Controlled Trial
NCT02357303 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia
NCT03205319 ·Status: COMPLETED ·Phase: NA
-
Association Between Luminal Bile Salt Content and Duodenal Mucosal Integrity in Functional Dyspepsia
NCT03003234 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
NCT02875678 ·Status: TERMINATED ·Phase: PHASE1
-
The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia
NCT05823636 ·Status: RECRUITING
-
Zypan Functional Dyspepsia
NCT06320379 ·Status: RECRUITING ·Phase: NA
-
Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms
NCT07250308 ·Status: RECRUITING
-
Effect of Zinc on Barrett's Metaplasia
NCT01984580 ·Status: UNKNOWN ·Phase: PHASE1
-
Treatment of Functional Dyspepsia With Acupuncture
NCT00786214 ·Status: COMPLETED ·Phase: NA
-
Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications
NCT04403087 ·Status: COMPLETED ·Phase: PHASE4
-
Intestinal Permeability in Children/Adolescents With Functional Dyspepsia
NCT00363597 ·Status: COMPLETED
-
Helicobacter Pylori and Proton Pump Inhibitor
NCT02449941 ·Status: COMPLETED
-
Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy
NCT05790525 ·Status: COMPLETED ·Phase: PHASE4